nodes	percent_of_prediction	percent_of_DWPC	metapath
Abacavir—UGT1A1—Irinotecan—colon cancer	0.561	1	CbGbCtD
Abacavir—ADH6—renal system—colon cancer	0.0323	0.236	CbGeAlD
Abacavir—ADH6—digestive system—colon cancer	0.0265	0.193	CbGeAlD
Abacavir—ADH6—liver—colon cancer	0.0197	0.144	CbGeAlD
Abacavir—ADK—smooth muscle tissue—colon cancer	0.00777	0.0567	CbGeAlD
Abacavir—ADK—renal system—colon cancer	0.00748	0.0546	CbGeAlD
Abacavir—UGT1A1—renal system—colon cancer	0.00738	0.0539	CbGeAlD
Abacavir—ADK—lymphoid tissue—colon cancer	0.00621	0.0453	CbGeAlD
Abacavir—UGT1A1—digestive system—colon cancer	0.00605	0.0442	CbGeAlD
Abacavir—ADK—bone marrow—colon cancer	0.00565	0.0413	CbGeAlD
Abacavir—ADK—vagina—colon cancer	0.00542	0.0395	CbGeAlD
Abacavir—ADK—liver—colon cancer	0.00457	0.0334	CbGeAlD
Abacavir—UGT1A1—liver—colon cancer	0.00451	0.0329	CbGeAlD
Abacavir—ADK—lymph node—colon cancer	0.0035	0.0256	CbGeAlD
Abacavir—Pneumonia—Fluorouracil—colon cancer	0.0014	0.00463	CcSEcCtD
Abacavir—Acute coronary syndrome—Fluorouracil—colon cancer	0.00137	0.00453	CcSEcCtD
Abacavir—Myocardial infarction—Fluorouracil—colon cancer	0.00136	0.00451	CcSEcCtD
Abacavir—Neuropathy peripheral—Fluorouracil—colon cancer	0.00136	0.00451	CcSEcCtD
Abacavir—Stomatitis—Fluorouracil—colon cancer	0.00136	0.00448	CcSEcCtD
Abacavir—Conjunctivitis—Fluorouracil—colon cancer	0.00135	0.00447	CcSEcCtD
Abacavir—Inflammation—Methotrexate—colon cancer	0.00133	0.00441	CcSEcCtD
Abacavir—Respiratory failure—Methotrexate—colon cancer	0.00132	0.00435	CcSEcCtD
Abacavir—Connective tissue disorder—Vincristine—colon cancer	0.00132	0.00435	CcSEcCtD
Abacavir—Lethargy—Capecitabine—colon cancer	0.00129	0.00426	CcSEcCtD
Abacavir—Connective tissue disorder—Irinotecan—colon cancer	0.00128	0.00424	CcSEcCtD
Abacavir—Migraine—Capecitabine—colon cancer	0.00124	0.0041	CcSEcCtD
Abacavir—Pharyngitis—Fluorouracil—colon cancer	0.00124	0.0041	CcSEcCtD
Abacavir—Aplastic anaemia—Methotrexate—colon cancer	0.00121	0.00402	CcSEcCtD
Abacavir—Alopecia—Vincristine—colon cancer	0.00118	0.00391	CcSEcCtD
Abacavir—Blood creatinine increased—Capecitabine—colon cancer	0.00118	0.00391	CcSEcCtD
Abacavir—Immune system disorder—Irinotecan—colon cancer	0.00118	0.00389	CcSEcCtD
Abacavir—Chills—Irinotecan—colon cancer	0.00117	0.00387	CcSEcCtD
Abacavir—Mouth ulceration—Methotrexate—colon cancer	0.00117	0.00387	CcSEcCtD
Abacavir—Liver function test abnormal—Capecitabine—colon cancer	0.00116	0.00385	CcSEcCtD
Abacavir—Alopecia—Irinotecan—colon cancer	0.00115	0.00381	CcSEcCtD
Abacavir—Abdominal pain upper—Capecitabine—colon cancer	0.00115	0.00381	CcSEcCtD
Abacavir—Toxic epidermal necrolysis—Capecitabine—colon cancer	0.00114	0.00376	CcSEcCtD
Abacavir—Aspartate aminotransferase increased—Capecitabine—colon cancer	0.00114	0.00376	CcSEcCtD
Abacavir—Gastritis—Capecitabine—colon cancer	0.00112	0.00369	CcSEcCtD
Abacavir—Muscular weakness—Capecitabine—colon cancer	0.00111	0.00368	CcSEcCtD
Abacavir—Alanine aminotransferase increased—Capecitabine—colon cancer	0.00111	0.00368	CcSEcCtD
Abacavir—Alopecia—Fluorouracil—colon cancer	0.0011	0.00365	CcSEcCtD
Abacavir—Lymphadenopathy—Methotrexate—colon cancer	0.0011	0.00364	CcSEcCtD
Abacavir—Anaemia—Vincristine—colon cancer	0.00108	0.00356	CcSEcCtD
Abacavir—Ill-defined disorder—Irinotecan—colon cancer	0.00105	0.00348	CcSEcCtD
Abacavir—Anaemia—Irinotecan—colon cancer	0.00105	0.00347	CcSEcCtD
Abacavir—Bronchitis—Capecitabine—colon cancer	0.00105	0.00347	CcSEcCtD
Abacavir—Vertigo—Vincristine—colon cancer	0.00105	0.00346	CcSEcCtD
Abacavir—Abdominal discomfort—Capecitabine—colon cancer	0.00104	0.00346	CcSEcCtD
Abacavir—Hepatic failure—Methotrexate—colon cancer	0.00104	0.00345	CcSEcCtD
Abacavir—Leukopenia—Vincristine—colon cancer	0.00104	0.00345	CcSEcCtD
Abacavir—Malaise—Irinotecan—colon cancer	0.00102	0.00338	CcSEcCtD
Abacavir—Vertigo—Irinotecan—colon cancer	0.00102	0.00337	CcSEcCtD
Abacavir—Neutropenia—Capecitabine—colon cancer	0.00102	0.00337	CcSEcCtD
Abacavir—Leukopenia—Irinotecan—colon cancer	0.00102	0.00336	CcSEcCtD
Abacavir—Convulsion—Vincristine—colon cancer	0.00101	0.00334	CcSEcCtD
Abacavir—Anaemia—Fluorouracil—colon cancer	0.001	0.00332	CcSEcCtD
Abacavir—Myalgia—Vincristine—colon cancer	0.000992	0.00328	CcSEcCtD
Abacavir—Cough—Irinotecan—colon cancer	0.00099	0.00327	CcSEcCtD
Abacavir—Hyperglycaemia—Capecitabine—colon cancer	0.000983	0.00325	CcSEcCtD
Abacavir—Pneumonia—Capecitabine—colon cancer	0.000977	0.00323	CcSEcCtD
Abacavir—Leukopenia—Fluorouracil—colon cancer	0.000973	0.00322	CcSEcCtD
Abacavir—Depression—Capecitabine—colon cancer	0.000969	0.0032	CcSEcCtD
Abacavir—Stevens-Johnson syndrome—Capecitabine—colon cancer	0.000963	0.00319	CcSEcCtD
Abacavir—Acute coronary syndrome—Capecitabine—colon cancer	0.000958	0.00317	CcSEcCtD
Abacavir—Lethargy—Methotrexate—colon cancer	0.000958	0.00317	CcSEcCtD
Abacavir—Renal failure—Capecitabine—colon cancer	0.000955	0.00316	CcSEcCtD
Abacavir—Discomfort—Irinotecan—colon cancer	0.000954	0.00316	CcSEcCtD
Abacavir—Neuropathy peripheral—Capecitabine—colon cancer	0.000953	0.00315	CcSEcCtD
Abacavir—Myocardial infarction—Capecitabine—colon cancer	0.000953	0.00315	CcSEcCtD
Abacavir—Oedema—Vincristine—colon cancer	0.000951	0.00314	CcSEcCtD
Abacavir—Anaphylactic shock—Vincristine—colon cancer	0.000951	0.00314	CcSEcCtD
Abacavir—Stomatitis—Capecitabine—colon cancer	0.000947	0.00313	CcSEcCtD
Abacavir—Infection—Vincristine—colon cancer	0.000945	0.00312	CcSEcCtD
Abacavir—Conjunctivitis—Capecitabine—colon cancer	0.000945	0.00312	CcSEcCtD
Abacavir—Convulsion—Fluorouracil—colon cancer	0.000942	0.00311	CcSEcCtD
Abacavir—Nervous system disorder—Vincristine—colon cancer	0.000932	0.00308	CcSEcCtD
Abacavir—Thrombocytopenia—Vincristine—colon cancer	0.000931	0.00308	CcSEcCtD
Abacavir—Oedema—Irinotecan—colon cancer	0.000926	0.00306	CcSEcCtD
Abacavir—Anaphylactic shock—Irinotecan—colon cancer	0.000926	0.00306	CcSEcCtD
Abacavir—Myalgia—Fluorouracil—colon cancer	0.000925	0.00306	CcSEcCtD
Abacavir—Infection—Irinotecan—colon cancer	0.00092	0.00304	CcSEcCtD
Abacavir—Hepatobiliary disease—Capecitabine—colon cancer	0.000919	0.00304	CcSEcCtD
Abacavir—Discomfort—Fluorouracil—colon cancer	0.000914	0.00302	CcSEcCtD
Abacavir—Nervous system disorder—Irinotecan—colon cancer	0.000908	0.003	CcSEcCtD
Abacavir—Thrombocytopenia—Irinotecan—colon cancer	0.000907	0.003	CcSEcCtD
Abacavir—Anorexia—Vincristine—colon cancer	0.000906	0.003	CcSEcCtD
Abacavir—Hypotension—Vincristine—colon cancer	0.000889	0.00294	CcSEcCtD
Abacavir—Oedema—Fluorouracil—colon cancer	0.000887	0.00293	CcSEcCtD
Abacavir—Anaphylactic shock—Fluorouracil—colon cancer	0.000887	0.00293	CcSEcCtD
Abacavir—Anorexia—Irinotecan—colon cancer	0.000883	0.00292	CcSEcCtD
Abacavir—Infection—Fluorouracil—colon cancer	0.000881	0.00291	CcSEcCtD
Abacavir—Hepatitis—Capecitabine—colon cancer	0.000872	0.00288	CcSEcCtD
Abacavir—Nervous system disorder—Fluorouracil—colon cancer	0.00087	0.00288	CcSEcCtD
Abacavir—Thrombocytopenia—Fluorouracil—colon cancer	0.000868	0.00287	CcSEcCtD
Abacavir—Liver function test abnormal—Methotrexate—colon cancer	0.000867	0.00287	CcSEcCtD
Abacavir—Musculoskeletal discomfort—Vincristine—colon cancer	0.000866	0.00286	CcSEcCtD
Abacavir—Pharyngitis—Capecitabine—colon cancer	0.000866	0.00286	CcSEcCtD
Abacavir—Hypotension—Irinotecan—colon cancer	0.000865	0.00286	CcSEcCtD
Abacavir—Insomnia—Vincristine—colon cancer	0.00086	0.00284	CcSEcCtD
Abacavir—Connective tissue disorder—Capecitabine—colon cancer	0.000857	0.00283	CcSEcCtD
Abacavir—Paraesthesia—Vincristine—colon cancer	0.000854	0.00282	CcSEcCtD
Abacavir—Anorexia—Fluorouracil—colon cancer	0.000845	0.0028	CcSEcCtD
Abacavir—Toxic epidermal necrolysis—Methotrexate—colon cancer	0.000845	0.0028	CcSEcCtD
Abacavir—Insomnia—Irinotecan—colon cancer	0.000838	0.00277	CcSEcCtD
Abacavir—Paraesthesia—Irinotecan—colon cancer	0.000832	0.00275	CcSEcCtD
Abacavir—Hypotension—Fluorouracil—colon cancer	0.000829	0.00274	CcSEcCtD
Abacavir—Decreased appetite—Vincristine—colon cancer	0.000827	0.00273	CcSEcCtD
Abacavir—Dyspnoea—Irinotecan—colon cancer	0.000826	0.00273	CcSEcCtD
Abacavir—Erythema multiforme—Capecitabine—colon cancer	0.000825	0.00273	CcSEcCtD
Abacavir—Gastrointestinal disorder—Vincristine—colon cancer	0.000821	0.00271	CcSEcCtD
Abacavir—Fatigue—Vincristine—colon cancer	0.00082	0.00271	CcSEcCtD
Abacavir—Pain—Vincristine—colon cancer	0.000813	0.00269	CcSEcCtD
Abacavir—Musculoskeletal discomfort—Fluorouracil—colon cancer	0.000808	0.00267	CcSEcCtD
Abacavir—Decreased appetite—Irinotecan—colon cancer	0.000805	0.00266	CcSEcCtD
Abacavir—Insomnia—Fluorouracil—colon cancer	0.000802	0.00265	CcSEcCtD
Abacavir—Gastrointestinal disorder—Irinotecan—colon cancer	0.000799	0.00264	CcSEcCtD
Abacavir—Fatigue—Irinotecan—colon cancer	0.000798	0.00264	CcSEcCtD
Abacavir—Paraesthesia—Fluorouracil—colon cancer	0.000796	0.00263	CcSEcCtD
Abacavir—Pancreatitis—Methotrexate—colon cancer	0.000795	0.00263	CcSEcCtD
Abacavir—Pain—Irinotecan—colon cancer	0.000792	0.00262	CcSEcCtD
Abacavir—Dyspnoea—Fluorouracil—colon cancer	0.000791	0.00261	CcSEcCtD
Abacavir—Immune system disorder—Capecitabine—colon cancer	0.000788	0.00261	CcSEcCtD
Abacavir—Chills—Capecitabine—colon cancer	0.000783	0.00259	CcSEcCtD
Abacavir—Abdominal discomfort—Methotrexate—colon cancer	0.000778	0.00257	CcSEcCtD
Abacavir—Gastrointestinal pain—Vincristine—colon cancer	0.000778	0.00257	CcSEcCtD
Abacavir—Decreased appetite—Fluorouracil—colon cancer	0.000771	0.00255	CcSEcCtD
Abacavir—Alopecia—Capecitabine—colon cancer	0.000771	0.00255	CcSEcCtD
Abacavir—Gastrointestinal disorder—Fluorouracil—colon cancer	0.000766	0.00253	CcSEcCtD
Abacavir—Feeling abnormal—Irinotecan—colon cancer	0.000763	0.00252	CcSEcCtD
Abacavir—Malnutrition—Capecitabine—colon cancer	0.000759	0.00251	CcSEcCtD
Abacavir—Neutropenia—Methotrexate—colon cancer	0.000759	0.00251	CcSEcCtD
Abacavir—Pain—Fluorouracil—colon cancer	0.000758	0.00251	CcSEcCtD
Abacavir—Gastrointestinal pain—Irinotecan—colon cancer	0.000757	0.0025	CcSEcCtD
Abacavir—Body temperature increased—Vincristine—colon cancer	0.000752	0.00249	CcSEcCtD
Abacavir—Abdominal pain—Vincristine—colon cancer	0.000752	0.00249	CcSEcCtD
Abacavir—Abdominal pain—Irinotecan—colon cancer	0.000732	0.00242	CcSEcCtD
Abacavir—Body temperature increased—Irinotecan—colon cancer	0.000732	0.00242	CcSEcCtD
Abacavir—Feeling abnormal—Fluorouracil—colon cancer	0.000731	0.00242	CcSEcCtD
Abacavir—Pneumonia—Methotrexate—colon cancer	0.000728	0.00241	CcSEcCtD
Abacavir—Depression—Methotrexate—colon cancer	0.000721	0.00239	CcSEcCtD
Abacavir—Stevens-Johnson syndrome—Methotrexate—colon cancer	0.000717	0.00237	CcSEcCtD
Abacavir—Renal failure—Methotrexate—colon cancer	0.000711	0.00235	CcSEcCtD
Abacavir—Stomatitis—Methotrexate—colon cancer	0.000705	0.00233	CcSEcCtD
Abacavir—Ill-defined disorder—Capecitabine—colon cancer	0.000705	0.00233	CcSEcCtD
Abacavir—Urticaria—Fluorouracil—colon cancer	0.000705	0.00233	CcSEcCtD
Abacavir—Conjunctivitis—Methotrexate—colon cancer	0.000703	0.00233	CcSEcCtD
Abacavir—Anaemia—Capecitabine—colon cancer	0.000702	0.00232	CcSEcCtD
Abacavir—Body temperature increased—Fluorouracil—colon cancer	0.000701	0.00232	CcSEcCtD
Abacavir—Hypersensitivity—Vincristine—colon cancer	0.000701	0.00232	CcSEcCtD
Abacavir—Malaise—Capecitabine—colon cancer	0.000685	0.00226	CcSEcCtD
Abacavir—Hepatobiliary disease—Methotrexate—colon cancer	0.000684	0.00226	CcSEcCtD
Abacavir—Vertigo—Capecitabine—colon cancer	0.000682	0.00226	CcSEcCtD
Abacavir—Hypersensitivity—Irinotecan—colon cancer	0.000682	0.00226	CcSEcCtD
Abacavir—Asthenia—Vincristine—colon cancer	0.000682	0.00226	CcSEcCtD
Abacavir—Leukopenia—Capecitabine—colon cancer	0.00068	0.00225	CcSEcCtD
Abacavir—Asthenia—Irinotecan—colon cancer	0.000664	0.0022	CcSEcCtD
Abacavir—Cough—Capecitabine—colon cancer	0.000663	0.00219	CcSEcCtD
Abacavir—Hypersensitivity—Fluorouracil—colon cancer	0.000653	0.00216	CcSEcCtD
Abacavir—Diarrhoea—Vincristine—colon cancer	0.000651	0.00215	CcSEcCtD
Abacavir—Hepatitis—Methotrexate—colon cancer	0.000649	0.00215	CcSEcCtD
Abacavir—Arthralgia—Capecitabine—colon cancer	0.000647	0.00214	CcSEcCtD
Abacavir—Myalgia—Capecitabine—colon cancer	0.000647	0.00214	CcSEcCtD
Abacavir—Pharyngitis—Methotrexate—colon cancer	0.000645	0.00213	CcSEcCtD
Abacavir—Anxiety—Capecitabine—colon cancer	0.000644	0.00213	CcSEcCtD
Abacavir—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—colon cancer	0.000642	0.00212	CcSEcCtD
Abacavir—Discomfort—Capecitabine—colon cancer	0.000639	0.00211	CcSEcCtD
Abacavir—Diarrhoea—Irinotecan—colon cancer	0.000634	0.0021	CcSEcCtD
Abacavir—Dizziness—Vincristine—colon cancer	0.000629	0.00208	CcSEcCtD
Abacavir—Pruritus—Fluorouracil—colon cancer	0.000627	0.00208	CcSEcCtD
Abacavir—Oedema—Capecitabine—colon cancer	0.00062	0.00205	CcSEcCtD
Abacavir—Infection—Capecitabine—colon cancer	0.000616	0.00204	CcSEcCtD
Abacavir—Erythema multiforme—Methotrexate—colon cancer	0.000614	0.00203	CcSEcCtD
Abacavir—Dizziness—Irinotecan—colon cancer	0.000612	0.00203	CcSEcCtD
Abacavir—Nervous system disorder—Capecitabine—colon cancer	0.000608	0.00201	CcSEcCtD
Abacavir—Diarrhoea—Fluorouracil—colon cancer	0.000607	0.00201	CcSEcCtD
Abacavir—Thrombocytopenia—Capecitabine—colon cancer	0.000607	0.00201	CcSEcCtD
Abacavir—Vomiting—Vincristine—colon cancer	0.000605	0.002	CcSEcCtD
Abacavir—Skin disorder—Capecitabine—colon cancer	0.000602	0.00199	CcSEcCtD
Abacavir—Rash—Vincristine—colon cancer	0.0006	0.00198	CcSEcCtD
Abacavir—Dermatitis—Vincristine—colon cancer	0.000599	0.00198	CcSEcCtD
Abacavir—Headache—Vincristine—colon cancer	0.000596	0.00197	CcSEcCtD
Abacavir—Anorexia—Capecitabine—colon cancer	0.000591	0.00195	CcSEcCtD
Abacavir—Vomiting—Irinotecan—colon cancer	0.000589	0.00195	CcSEcCtD
Abacavir—Immune system disorder—Methotrexate—colon cancer	0.000587	0.00194	CcSEcCtD
Abacavir—Dizziness—Fluorouracil—colon cancer	0.000586	0.00194	CcSEcCtD
Abacavir—Rash—Irinotecan—colon cancer	0.000584	0.00193	CcSEcCtD
Abacavir—Dermatitis—Irinotecan—colon cancer	0.000583	0.00193	CcSEcCtD
Abacavir—Chills—Methotrexate—colon cancer	0.000583	0.00193	CcSEcCtD
Abacavir—Headache—Irinotecan—colon cancer	0.00058	0.00192	CcSEcCtD
Abacavir—Hypotension—Capecitabine—colon cancer	0.000579	0.00192	CcSEcCtD
Abacavir—Alopecia—Methotrexate—colon cancer	0.000574	0.0019	CcSEcCtD
Abacavir—Malnutrition—Methotrexate—colon cancer	0.000565	0.00187	CcSEcCtD
Abacavir—Nausea—Vincristine—colon cancer	0.000565	0.00187	CcSEcCtD
Abacavir—Musculoskeletal discomfort—Capecitabine—colon cancer	0.000565	0.00187	CcSEcCtD
Abacavir—Vomiting—Fluorouracil—colon cancer	0.000564	0.00186	CcSEcCtD
Abacavir—Insomnia—Capecitabine—colon cancer	0.000561	0.00185	CcSEcCtD
Abacavir—Rash—Fluorouracil—colon cancer	0.000559	0.00185	CcSEcCtD
Abacavir—Dermatitis—Fluorouracil—colon cancer	0.000559	0.00185	CcSEcCtD
Abacavir—Paraesthesia—Capecitabine—colon cancer	0.000557	0.00184	CcSEcCtD
Abacavir—Headache—Fluorouracil—colon cancer	0.000556	0.00184	CcSEcCtD
Abacavir—Dyspnoea—Capecitabine—colon cancer	0.000553	0.00183	CcSEcCtD
Abacavir—Nausea—Irinotecan—colon cancer	0.00055	0.00182	CcSEcCtD
Abacavir—Decreased appetite—Capecitabine—colon cancer	0.000539	0.00178	CcSEcCtD
Abacavir—Gastrointestinal disorder—Capecitabine—colon cancer	0.000535	0.00177	CcSEcCtD
Abacavir—Fatigue—Capecitabine—colon cancer	0.000534	0.00177	CcSEcCtD
Abacavir—Pain—Capecitabine—colon cancer	0.00053	0.00175	CcSEcCtD
Abacavir—Nausea—Fluorouracil—colon cancer	0.000527	0.00174	CcSEcCtD
Abacavir—Ill-defined disorder—Methotrexate—colon cancer	0.000525	0.00173	CcSEcCtD
Abacavir—Anaemia—Methotrexate—colon cancer	0.000523	0.00173	CcSEcCtD
Abacavir—Feeling abnormal—Capecitabine—colon cancer	0.000511	0.00169	CcSEcCtD
Abacavir—Malaise—Methotrexate—colon cancer	0.00051	0.00169	CcSEcCtD
Abacavir—Vertigo—Methotrexate—colon cancer	0.000508	0.00168	CcSEcCtD
Abacavir—Gastrointestinal pain—Capecitabine—colon cancer	0.000507	0.00168	CcSEcCtD
Abacavir—Leukopenia—Methotrexate—colon cancer	0.000506	0.00167	CcSEcCtD
Abacavir—Cough—Methotrexate—colon cancer	0.000493	0.00163	CcSEcCtD
Abacavir—Urticaria—Capecitabine—colon cancer	0.000492	0.00163	CcSEcCtD
Abacavir—Body temperature increased—Capecitabine—colon cancer	0.00049	0.00162	CcSEcCtD
Abacavir—Abdominal pain—Capecitabine—colon cancer	0.00049	0.00162	CcSEcCtD
Abacavir—Convulsion—Methotrexate—colon cancer	0.00049	0.00162	CcSEcCtD
Abacavir—Arthralgia—Methotrexate—colon cancer	0.000481	0.00159	CcSEcCtD
Abacavir—Myalgia—Methotrexate—colon cancer	0.000481	0.00159	CcSEcCtD
Abacavir—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—colon cancer	0.000478	0.00158	CcSEcCtD
Abacavir—Discomfort—Methotrexate—colon cancer	0.000476	0.00157	CcSEcCtD
Abacavir—Anaphylactic shock—Methotrexate—colon cancer	0.000461	0.00153	CcSEcCtD
Abacavir—Infection—Methotrexate—colon cancer	0.000458	0.00152	CcSEcCtD
Abacavir—Hypersensitivity—Capecitabine—colon cancer	0.000457	0.00151	CcSEcCtD
Abacavir—Nervous system disorder—Methotrexate—colon cancer	0.000452	0.0015	CcSEcCtD
Abacavir—Thrombocytopenia—Methotrexate—colon cancer	0.000452	0.00149	CcSEcCtD
Abacavir—Skin disorder—Methotrexate—colon cancer	0.000448	0.00148	CcSEcCtD
Abacavir—Asthenia—Capecitabine—colon cancer	0.000445	0.00147	CcSEcCtD
Abacavir—Anorexia—Methotrexate—colon cancer	0.00044	0.00145	CcSEcCtD
Abacavir—Pruritus—Capecitabine—colon cancer	0.000438	0.00145	CcSEcCtD
Abacavir—Hypotension—Methotrexate—colon cancer	0.000431	0.00143	CcSEcCtD
Abacavir—Diarrhoea—Capecitabine—colon cancer	0.000424	0.0014	CcSEcCtD
Abacavir—Musculoskeletal discomfort—Methotrexate—colon cancer	0.00042	0.00139	CcSEcCtD
Abacavir—Insomnia—Methotrexate—colon cancer	0.000417	0.00138	CcSEcCtD
Abacavir—Paraesthesia—Methotrexate—colon cancer	0.000414	0.00137	CcSEcCtD
Abacavir—Dyspnoea—Methotrexate—colon cancer	0.000411	0.00136	CcSEcCtD
Abacavir—Dizziness—Capecitabine—colon cancer	0.00041	0.00136	CcSEcCtD
Abacavir—Decreased appetite—Methotrexate—colon cancer	0.000401	0.00133	CcSEcCtD
Abacavir—Gastrointestinal disorder—Methotrexate—colon cancer	0.000398	0.00132	CcSEcCtD
Abacavir—Fatigue—Methotrexate—colon cancer	0.000398	0.00132	CcSEcCtD
Abacavir—Pain—Methotrexate—colon cancer	0.000395	0.0013	CcSEcCtD
Abacavir—Vomiting—Capecitabine—colon cancer	0.000394	0.0013	CcSEcCtD
Abacavir—Rash—Capecitabine—colon cancer	0.000391	0.00129	CcSEcCtD
Abacavir—Dermatitis—Capecitabine—colon cancer	0.00039	0.00129	CcSEcCtD
Abacavir—Headache—Capecitabine—colon cancer	0.000388	0.00128	CcSEcCtD
Abacavir—Feeling abnormal—Methotrexate—colon cancer	0.00038	0.00126	CcSEcCtD
Abacavir—Gastrointestinal pain—Methotrexate—colon cancer	0.000377	0.00125	CcSEcCtD
Abacavir—Nausea—Capecitabine—colon cancer	0.000368	0.00122	CcSEcCtD
Abacavir—Urticaria—Methotrexate—colon cancer	0.000367	0.00121	CcSEcCtD
Abacavir—Body temperature increased—Methotrexate—colon cancer	0.000365	0.00121	CcSEcCtD
Abacavir—Abdominal pain—Methotrexate—colon cancer	0.000365	0.00121	CcSEcCtD
Abacavir—Hypersensitivity—Methotrexate—colon cancer	0.00034	0.00112	CcSEcCtD
Abacavir—Asthenia—Methotrexate—colon cancer	0.000331	0.00109	CcSEcCtD
Abacavir—Pruritus—Methotrexate—colon cancer	0.000326	0.00108	CcSEcCtD
Abacavir—Diarrhoea—Methotrexate—colon cancer	0.000316	0.00104	CcSEcCtD
Abacavir—Dizziness—Methotrexate—colon cancer	0.000305	0.00101	CcSEcCtD
Abacavir—Vomiting—Methotrexate—colon cancer	0.000293	0.00097	CcSEcCtD
Abacavir—Rash—Methotrexate—colon cancer	0.000291	0.000962	CcSEcCtD
Abacavir—Dermatitis—Methotrexate—colon cancer	0.000291	0.000961	CcSEcCtD
Abacavir—Headache—Methotrexate—colon cancer	0.000289	0.000956	CcSEcCtD
Abacavir—Nausea—Methotrexate—colon cancer	0.000274	0.000906	CcSEcCtD
